Ilaria Grazia Zizzari | Ricerc@Sapienza

Publications

Title	Published on	Year
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy	FRONTIERS IN IMMUNOLOGY	2022
The role of soluble LAG3 and soluble immune checkpoints profile in advanced head and neck cancer: a pilot study	JOURNAL OF PERSONALIZED MEDICINE	2021
Anti–PD-1 and Anti–PD-L1 in head and neck cancer: a network meta-analysis	FRONTIERS IN IMMUNOLOGY	2021
Immunogenic cell death and immunomodulatory effects of cabozantinib	FRONTIERS IN ONCOLOGY	2021
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment	JOURNAL OF TRANSLATIONAL MEDICINE	2020
Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring	JOURNAL OF IMMUNOLOGY RESEARCH	2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1	FRONTIERS IN IMMUNOLOGY	2020
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma	JOURNAL OF PERSONALIZED MEDICINE	2020
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma	CANCERS	2020
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma	HEPATOLOGY	2020
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL)	CANCERS	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells	EBIOMEDICINE	2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells	ANNALS OF ONCOLOGY	2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients	JOURNAL OF PERSONALIZED MEDICINE	2020
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets	JOURNAL OF CLINICAL MEDICINE	2019
Immunological backbone of uveal melanoma: is there a rationale for immunotherapy?	CANCERS	2019
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab	JOURNAL OF TRANSLATIONAL MEDICINE	2019
Immune profile of metastatic uveal melanoma during treatment with pembrolizumab	JOURNAL OF CLINICAL ONCOLOGY	2019
HUMAN DUODENAL SUBMUCOSAL GLANDS CONTAIN STEM CELLS WITH POTENTIAL FOR LIVER AND PANCREATIC FATES	DIGESTIVE AND LIVER DISEASE	2019

ERC

LS6
LS6_2
LS6_3
LS6_11
LS7_2

Interessi di ricerca

Keywords

anticancer immunotherapy

anti-tumor immune response

biomarkers tumor

dendritic cells

Progetti di Ricerca

NETWORK MEDICINE IN IMMUNO-ONCOLOGY: INTEGRATING CLINICAL AND LABORATORY DATA TO GENERATE PRECISION ROADMAPS FOR CANCER PATIENTS
Impact of circulating immune molecules on clinical outcome of uveal melanoma patients
Prognostic and predictive role of microbioma in NSCLC patients treated with anti-PD1 therapy